# JUVÉDERM® VOLUMA® With Lidocaine for Correction of Temple Hollowing in Chinese Population

> **NCT04891419** · PHASE3 · COMPLETED · sponsor: **Allergan** · enrollment: 168 (actual)

## Conditions studied

- Temple Hollowing

## Interventions

- **DEVICE:** JUVÉDERM® VOLUMA® with Lidocaine

## Key facts

- **NCT ID:** NCT04891419
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-20
- **Primary completion:** 2023-11-22
- **Final completion:** 2023-11-22
- **Target enrollment:** 168 (ACTUAL)
- **Last updated:** 2024-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04891419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04891419, "JUVÉDERM® VOLUMA® With Lidocaine for Correction of Temple Hollowing in Chinese Population". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT04891419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*